Altering Dynamics of Autonomic Processing Therapy (ADAPT) trial: a novel, targeted treatment for reducing anxiety in joint hypermobility

Abstract Background Hypermobility is a poorly recognised and understood musculoskeletal disorder thought to affect around 20% of the population. Hypermobility is associated with reduced physiological and psychological functioning and quality of life and is a known risk factor for the development of...

Full description

Bibliographic Details
Main Authors: Geoff Davies, Jenny L. L. Csecs, Heather Ball, Jess Dare, Stephen Bremner, Robin Hosking, Hugo D. Critchley, Nick Grey, Jessica A. Eccles
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Trials
Subjects:
Online Access:https://doi.org/10.1186/s13063-021-05555-4
_version_ 1819111083788468224
author Geoff Davies
Jenny L. L. Csecs
Heather Ball
Jess Dare
Stephen Bremner
Robin Hosking
Hugo D. Critchley
Nick Grey
Jessica A. Eccles
author_facet Geoff Davies
Jenny L. L. Csecs
Heather Ball
Jess Dare
Stephen Bremner
Robin Hosking
Hugo D. Critchley
Nick Grey
Jessica A. Eccles
author_sort Geoff Davies
collection DOAJ
description Abstract Background Hypermobility is a poorly recognised and understood musculoskeletal disorder thought to affect around 20% of the population. Hypermobility is associated with reduced physiological and psychological functioning and quality of life and is a known risk factor for the development of an anxiety disorder. To date, no evidence-based, targeted treatment for anxiety in the context of hypermobility exists. The present intervention (ADAPT—Altering Dynamics of Autonomic Processing Therapy) is a novel therapy combining bio-behavioural training with cognitive approaches from clinical health psychology targeting the catastrophisation of internal sensations, with aim to improve autonomic trait prediction error. Method Eighty individuals with diagnosed hypermobility will be recruited and the efficacy of ADAPT to treat anxiety will be compared to an Emotion-Focused Supportive Therapy (EFST) comparator therapy in a randomised controlled trial. The primary treatment target will be post therapy score on the Beck Anxiety Inventory, and secondary outcomes will also be considered in relation to interoception, depression, alexithymia, social and work adjustment, panic symptoms and dissociation. Due to COVID restrictions, the intervention will be moved to online delivery and qualitative assessment of treatment tolerance to online therapy will also be assessed. Discussion Online delivery of an intervention targeting anxiety would improve the quality of life for those experiencing anxiety disorder and help to reduce the £11.7 billion that anxiety disorders cost the UK economy annually. Trial registration World Health Organization ISRCTN17018615 . Registered on 20th February 2019; trial protocol version 2
first_indexed 2024-12-22T03:51:59Z
format Article
id doaj.art-4bf57ec815644b5ab7e8a028a0f0e470
institution Directory Open Access Journal
issn 1745-6215
language English
last_indexed 2024-12-22T03:51:59Z
publishDate 2021-09-01
publisher BMC
record_format Article
series Trials
spelling doaj.art-4bf57ec815644b5ab7e8a028a0f0e4702022-12-21T18:39:58ZengBMCTrials1745-62152021-09-0122111010.1186/s13063-021-05555-4Altering Dynamics of Autonomic Processing Therapy (ADAPT) trial: a novel, targeted treatment for reducing anxiety in joint hypermobilityGeoff Davies0Jenny L. L. Csecs1Heather Ball2Jess Dare3Stephen Bremner4Robin Hosking5Hugo D. Critchley6Nick Grey7Jessica A. Eccles8Department of Neuroscience, Brighton and Sussex Medical School, University of SussexDepartment of Neuroscience, Brighton and Sussex Medical School, University of SussexSussex Partnership NHS Foundation TrustSussex Community NHS Foundation TrustBrighton and Sussex Clinical Trials Unit, Brighton & Sussex Medical SchoolSussex Partnership NHS Foundation TrustDepartment of Neuroscience, Brighton and Sussex Medical School, University of SussexSussex Partnership NHS Foundation TrustDepartment of Neuroscience, Brighton and Sussex Medical School, University of SussexAbstract Background Hypermobility is a poorly recognised and understood musculoskeletal disorder thought to affect around 20% of the population. Hypermobility is associated with reduced physiological and psychological functioning and quality of life and is a known risk factor for the development of an anxiety disorder. To date, no evidence-based, targeted treatment for anxiety in the context of hypermobility exists. The present intervention (ADAPT—Altering Dynamics of Autonomic Processing Therapy) is a novel therapy combining bio-behavioural training with cognitive approaches from clinical health psychology targeting the catastrophisation of internal sensations, with aim to improve autonomic trait prediction error. Method Eighty individuals with diagnosed hypermobility will be recruited and the efficacy of ADAPT to treat anxiety will be compared to an Emotion-Focused Supportive Therapy (EFST) comparator therapy in a randomised controlled trial. The primary treatment target will be post therapy score on the Beck Anxiety Inventory, and secondary outcomes will also be considered in relation to interoception, depression, alexithymia, social and work adjustment, panic symptoms and dissociation. Due to COVID restrictions, the intervention will be moved to online delivery and qualitative assessment of treatment tolerance to online therapy will also be assessed. Discussion Online delivery of an intervention targeting anxiety would improve the quality of life for those experiencing anxiety disorder and help to reduce the £11.7 billion that anxiety disorders cost the UK economy annually. Trial registration World Health Organization ISRCTN17018615 . Registered on 20th February 2019; trial protocol version 2https://doi.org/10.1186/s13063-021-05555-4HypermobilityAnxietyCBTInteroceptionRCT
spellingShingle Geoff Davies
Jenny L. L. Csecs
Heather Ball
Jess Dare
Stephen Bremner
Robin Hosking
Hugo D. Critchley
Nick Grey
Jessica A. Eccles
Altering Dynamics of Autonomic Processing Therapy (ADAPT) trial: a novel, targeted treatment for reducing anxiety in joint hypermobility
Trials
Hypermobility
Anxiety
CBT
Interoception
RCT
title Altering Dynamics of Autonomic Processing Therapy (ADAPT) trial: a novel, targeted treatment for reducing anxiety in joint hypermobility
title_full Altering Dynamics of Autonomic Processing Therapy (ADAPT) trial: a novel, targeted treatment for reducing anxiety in joint hypermobility
title_fullStr Altering Dynamics of Autonomic Processing Therapy (ADAPT) trial: a novel, targeted treatment for reducing anxiety in joint hypermobility
title_full_unstemmed Altering Dynamics of Autonomic Processing Therapy (ADAPT) trial: a novel, targeted treatment for reducing anxiety in joint hypermobility
title_short Altering Dynamics of Autonomic Processing Therapy (ADAPT) trial: a novel, targeted treatment for reducing anxiety in joint hypermobility
title_sort altering dynamics of autonomic processing therapy adapt trial a novel targeted treatment for reducing anxiety in joint hypermobility
topic Hypermobility
Anxiety
CBT
Interoception
RCT
url https://doi.org/10.1186/s13063-021-05555-4
work_keys_str_mv AT geoffdavies alteringdynamicsofautonomicprocessingtherapyadapttrialanoveltargetedtreatmentforreducinganxietyinjointhypermobility
AT jennyllcsecs alteringdynamicsofautonomicprocessingtherapyadapttrialanoveltargetedtreatmentforreducinganxietyinjointhypermobility
AT heatherball alteringdynamicsofautonomicprocessingtherapyadapttrialanoveltargetedtreatmentforreducinganxietyinjointhypermobility
AT jessdare alteringdynamicsofautonomicprocessingtherapyadapttrialanoveltargetedtreatmentforreducinganxietyinjointhypermobility
AT stephenbremner alteringdynamicsofautonomicprocessingtherapyadapttrialanoveltargetedtreatmentforreducinganxietyinjointhypermobility
AT robinhosking alteringdynamicsofautonomicprocessingtherapyadapttrialanoveltargetedtreatmentforreducinganxietyinjointhypermobility
AT hugodcritchley alteringdynamicsofautonomicprocessingtherapyadapttrialanoveltargetedtreatmentforreducinganxietyinjointhypermobility
AT nickgrey alteringdynamicsofautonomicprocessingtherapyadapttrialanoveltargetedtreatmentforreducinganxietyinjointhypermobility
AT jessicaaeccles alteringdynamicsofautonomicprocessingtherapyadapttrialanoveltargetedtreatmentforreducinganxietyinjointhypermobility